BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...
1d
AZoLifeSciences on MSNStanford Researchers Find a Molecule That Rivals Ozempic in Weight LossBRP emerges as a promising peptide for weight loss, activating appetite control pathways without triggering nausea, paving ...
Wearable and implantable biosensors that can accurately detect biological molecules in a non- or minimally invasive manner ...
Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...
Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...
The common diabetes drug metformin works partly by excreting sugar from the bloodstream into the intestines, where gut ...
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...
Portuguese researchers identified a type of immune cell that appears to travel to the pancreas to stimulate glucagon ...
A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide - also known as Ozempic - in suppressing appetite and reducing body weight.
"Intestinal glucose excretion represents a previously unrecognized physiological process. Understanding its molecular mechanisms and how drugs influence this system could lead to the development of ...
Researchers have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity - a harmful condition linked to the progression of type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results